middle.news
How Did IMEXHS Achieve Top-End FY25 Revenue and EBITDA Growth?
10:54am on Friday 30th of January, 2026 AEDT
•
Healthcare
Read Story
How Did IMEXHS Achieve Top-End FY25 Revenue and EBITDA Growth?
10:54am on Friday 30th of January, 2026 AEDT
Key Points
FY25 revenue of $29.0 million, up 10% year-on-year
Underlying EBITDA rises to $1.6 million, tripling prior year
Annualised Recurring Revenue (ARR) grows 16% to $34.8 million
Strong Q4 software revenue growth and key contract renewals
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
IMEXHS (ASX:IME)
OPEN ARTICLE